Sponsorluk
Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection
Posted
Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.
Site içinde arama yapın
Kategoriler
- National
- International
- Business
- Technology
- Health
- EĞİTİM BİLGİLERİ
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
'Anyone would do a better job': Trump's 'no talent' dig at late-night show hosts; US President says Jimmy Fallon and Kimmel 'are next' after Stephen Colbert
Donald Trump asserted that late-night hosts Stephen Colbert, Jimmy Kimmel, and Jimmy Fallon lack...
Her bones tell Gaza story, but Grok thinks it is Yemen: Musk's chatbot flagged for false claims on starving girl photo - Can AI be trusted?
A recent photograph from Gaza, depicting a severely malnourished girl, has ignited controversy...
Warren Buffett shares one ‘simple’ tip for evaluating a company before investing and how to avoid costly mistakes
Warren Buffett's investment philosophy emphasizes the 'circle of competence,' urging investors to...